Furthermore, G-protein-coupled receptor (GPCR) and integrin-focal adhesion kinase (FAK) signaling are upstream targets of activated extracellular signal-regulated kinase (ERK)38,39, thereby increasing the stemness of thyroid cancer cells. This evidence concerns the gene PTK2 and thyroid gland carcinoma.